KRAS, ALK, c-MET, RET, BRAF V600E, ROS1, NTRK, TP53, and ERBB2 (HER2) [40] are among the actionable genetic changes found in NSCLC. This evidence concerns the gene BRAF and non-small cell lung carcinoma.